|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 31/167 | |||
| A61K 31/137 | |||
| A61K 31/135 | |||
| A61K 31/485 | |||
| A61K 31/375 |
| (11) | Number of the document | 2379057 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09795623.9 |
| Date of filing the European patent application | 2009-12-11 | |
| (97) | Date of publication of the European application | 2011-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2013-07-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/067618 |
| Date | 2009-12-11 |
| (87) | Number | WO 2010/080339 |
| Date | 2010-07-15 |
| (30) | Number | Date | Country code |
| 139391 P | 2008-12-19 | US |
| (72) |
DUNGAN, Timothy, US
WARRINGTON, Brian, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHENYLEPHRINE FORMULATIONS WITH IMPROVED STABILITY |
| PHENYLEPHRINE FORMULATIONS WITH IMPROVED STABILITY |